49 related articles for article (PubMed ID: 11212905)
21. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials.
Newlands ES; Stevens MF; Wedge SR; Wheelhouse RT; Brock C
Cancer Treat Rev; 1997 Jan; 23(1):35-61. PubMed ID: 9189180
[No Abstract] [Full Text] [Related]
22. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.
Fine HA; Dear KB; Loeffler JS; Black PM; Canellos GP
Cancer; 1993 Apr; 71(8):2585-97. PubMed ID: 8453582
[TBL] [Abstract][Full Text] [Related]
23. Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Plowman J; Waud WR; Koutsoukos AD; Rubinstein LV; Moore TD; Grever MR
Cancer Res; 1994 Jul; 54(14):3793-9. PubMed ID: 8033099
[TBL] [Abstract][Full Text] [Related]
24. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
[TBL] [Abstract][Full Text] [Related]
25. The basis for current treatment recommendations for malignant gliomas.
Fine HA
J Neurooncol; 1994; 20(2):111-20. PubMed ID: 7807189
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
Walker MD; Green SB; Byar DP; Alexander E; Batzdorf U; Brooks WH; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Owens G; Ransohoff J; Robertson JT; Shapiro WR; Smith KR; Wilson CB; Strike TA
N Engl J Med; 1980 Dec; 303(23):1323-9. PubMed ID: 7001230
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic effects of the methylating agent 5-(3-methyl-1-triazeno) imidazole-4-carboxamide in human melanoma cells.
Hayward IP; Parsons PG
Aust J Exp Biol Med Sci; 1984 Oct; 62 ( Pt 5)():597-606. PubMed ID: 6534346
[TBL] [Abstract][Full Text] [Related]
28. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
Chang CH; Horton J; Schoenfeld D; Salazer O; Perez-Tamayo R; Kramer S; Weinstein A; Nelson JS; Tsukada Y
Cancer; 1983 Sep; 52(6):997-1007. PubMed ID: 6349785
[TBL] [Abstract][Full Text] [Related]
29. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
Green SB; Byar DP; Walker MD; Pistenmaa DA; Alexander E; Batzdorf U; Brooks WH; Hunt WE; Mealey J; Odom GL; Paoletti P; Ransohoff J; Robertson JT; Selker RG; Shapiro WR; Smith KR; Wilson CB; Strike TA
Cancer Treat Rep; 1983 Feb; 67(2):121-32. PubMed ID: 6337710
[TBL] [Abstract][Full Text] [Related]
30. Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy.
Spassova MK; Golovinsky EV
Pharmacol Ther; 1985; 27(3):333-52. PubMed ID: 3901047
[No Abstract] [Full Text] [Related]
31. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine.
Stevens MF; Hickman JA; Langdon SP; Chubb D; Vickers L; Stone R; Baig G; Goddard C; Gibson NW; Slack JA
Cancer Res; 1987 Nov; 47(22):5846-52. PubMed ID: 3664486
[TBL] [Abstract][Full Text] [Related]
32. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
Nelson DF; Diener-West M; Horton J; Chang CH; Schoenfeld D; Nelson JS
NCI Monogr; 1988; (6):279-84. PubMed ID: 3281031
[TBL] [Abstract][Full Text] [Related]
33. Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma.
Buckner JC; Brown LD; Cascino TL; Gerstner JB; Krook JE; Westberg MW; Wiesenfeld M; O'Fallon JR; Scheithauer B
J Neurooncol; 1990 Dec; 9(3):249-54. PubMed ID: 2086739
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
Tsang LL; Quarterman CP; Gescher A; Slack JA
Cancer Chemother Pharmacol; 1991; 27(5):342-6. PubMed ID: 1998993
[TBL] [Abstract][Full Text] [Related]
35. The role of radiosurgery in the treatment of malignant brain tumors.
Coffey RJ; Lunsford LD; Flickinger JC
Neurosurg Clin N Am; 1992 Jan; 3(1):231-44. PubMed ID: 1633449
[TBL] [Abstract][Full Text] [Related]
36. Iodine-125 interstitial irradiation for cerebral gliomas.
Ostertag CB; Kreth FW
Acta Neurochir (Wien); 1992; 119(1-4):53-61. PubMed ID: 1481753
[TBL] [Abstract][Full Text] [Related]
37. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.
Pocock SJ; Simon R
Biometrics; 1975 Mar; 31(1):103-15. PubMed ID: 1100130
[TBL] [Abstract][Full Text] [Related]
38. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
Walker MD; Alexander E; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Norrell HA; Owens G; Ransohoff J; Wilson CB; Gehan EA; Strike TA
J Neurosurg; 1978 Sep; 49(3):333-43. PubMed ID: 355604
[TBL] [Abstract][Full Text] [Related]
40. Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441).
Taylor SG; Nelson L; Baxter D; Rosenbaum C; Sponzo RW; Cunningham TJ; Olson KB; Horton J
Cancer; 1975 Oct; 36(4):1269-76. PubMed ID: 169984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
